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custom-made Perspex plinth was used to hold each of the slices
which were then scanned at 37°C. Main perameters [2] are TEs
from 2.47 ms–16.9 ms (increment 2.01 ms) and a resolution of
1.2 × 1.2 × 5 mm3.
Results: Figure 1 shows example images acquired at Bangkok
and London including the ex vivo scan. Figure 2 shows two curve
fitting examples demonstrating the discrepancy in T2* measure-
ment using both the truncation and the offset model. The in vivo
and ex vivo measurements, however, agree well using the
truncation model. Table 1 summaries all T2* measurements using
different models. The mean value and standard deviation are also
calculated.
Conclusion: This study has demonstrated the good reprodu-
cibility of the myocardial T2* measurement using the truncation
model, where an in vivo T2* measurement from the patient data
agrees with ex vivo one of the fixed heart. These data, along with
the calibration study [5], support the clinical use of myocardial
T2* in iron overload syndromes.
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Introduction: A large percentage of thalassemia major (TM)
patients shows a significant heterogeneity of segmental distribu-
Table 1 (abstract P133) Summary of T2* measurements using both truncation and offset models
T2* (ms) Bangkok Baseline Bangkok Repeat London Bright Blood London Black Blood ex vivo Mean STD
Truncation Model 6.0 6.1 6.1 6.0 6.1 6.1 0.1
Offset Model 4.6 6.1 3.7 4.6 4.8 4.8 0.9
Figure 1 (abstract P134)
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tion of T2* values in myocardium, measured by multislice
multiecho T2* cardiac magnetic resonance (CMR). This finding is
in agreement with previous histological studies that have
detected heterogeneous iron deposition in hemochromatotic
hearts. However, it is not yet clear if that represented true
heterogeneous iron density or if it could have been generated by
geometric and susceptibility artefacts.
Purpose: The purpose of this study is to investigate myocardial
T2* heterogeneity in TM patients by CMR, and to determine if it
is related to inhomogeneous iron overload distribution.
Methods: 230 TM patients consecutively affered to our
laboratory were retrospectively studied. Three short-axis
views (basal, medium, and apical) of the left ventricle (LV) were
obtained by multislice multiecho T2* CMR. T2* segmental
distribution was mapped on a 16-segment LV model. The level of
heterogeneity of the T2* segmental distribution on each patient
was evaluated by the coefficient of variation. Measured hetero-
geneity was compared with that of a surrogate data set obtained
from measurements of subjects without iron overload, to
determine whether the inhomogeneous segmental distribution
of T2* could be generated only by susceptibility artefacts.
Results: In 45 (20%) TM patients, segmental T2* values were all
below the lower limit of normal (20 ms). In 104 (45%) patients,
T2* values were heterogeneous with respect to the normal
threshold. Of these patients, 74% showed a normal T2* global
value. Eighty-one (35%) patients had all normal segments (A). T2*
value heterogeneity assessed by the CoV in TM patients and in
the surrogate data is shown in Figure 1B. The white squares and
the black line represent single patient measurements and the
CoV average on all patients, respectively. The grey line represents
the mean CoV of the surrogate data with the mean ± 2 SD limits
(grey dotted lines). The mean and the normal lower limit of the
T2* global value assessed in the healthy subjects are shown as
well (vertical black arrows). T2* heterogeneity for patients
without iron overload was compatible with the hypothesis that
the heterogeneity was generated by susceptibility artefacts.
Below the lower limit of normal for global T2*, the heterogeneity
abruptly increased and could not be explained by artefactual
effects.
Conclusion: A true heterogeneity in iron overload distribution
may be present in TM patients. Heterogeneity seemingly appears
in the borderline myocardial iron and stabilizes for moderate to
severe iron burden.
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Introduction: Phase-contrast flow measurements have been
shown to accurately quantify blood flow in subjects with
structurally normal hearts and those with congenital heart
disease (CHD). There are a number of potential sources of error,
however, in phase-contrast CMR flow measurements, including
phase offset errors due to local non-compensated eddy currents.
Wolff and colleagues recently reported on the clinical application
of phantom correction of phase offset errors in adult volunteers
with structurally normal hearts [1]. The effect of phantom
correction on phase-contrast flow measurements in patients
with known or suspected heart disease has not previously been
reported.
Purpose: To assess whether phantom correction significantly
changed flow measurements by phase-contrast imaging in
patients referred to a congenital CMR program.
Methods: The clinical congenital cardiac magnetic resonance
imaging database at a single institution was searched for patients
who had examinations performed with phase contrast images
using phantom correction. Examinations were performed on a
GE Signa HDx 1.5 T scanner using commercially available coils
(GE Healthcare, Milwaukee, Wisconsin). Phase-contrast images
were acquired perpendicular to the vessel of interest using
orthogonal long-axis views of the vessel. Breathe-through images
were obtained using the commercially resident FastCine PC
pulse sequence with the Venc determined by clinical parameters.
The phase-contrast sequences were each repeated on a
stationary fluid phantom with an ECG simulator to establish a
baseline of zero velocity. Based on the clinical protocol, phase-
contrast images of flow were obtained in the ascending aorta
(AAO), main pulmonary artery (MPA), right pulmonary artery
(RPA), and/or left pulmonary artery (LPA) and analyzed with and
without phantom correction using GE ReportCard software
version 3.6. The ratio of pulmonary to systemic flow (Qp/Qs),
percent flow to the RPA (QpR fraction), pulmonary regurgitation
fraction (PR), and aortic regurgitation (AR) fraction were also
calculated with and without phantom correction. Clinically
significant changes in flow measurements with phantom correc-
tion were defined prior to analysis: a change in MPA or AAo flow
≥ 0.5 L/min/m2, change in RPA or LPA flow ≥ 0.25 L/min/m2,
change in Qp/Qs ≥ 0.4, change in QpR fraction ≥ 10%, and
change in PR or AR fraction ≥ 10%. Marked changes in flow
measurements were defined as double the amount of clinically
significant change in each category – for example, a change in
MPA flow ≥ 1.0 L/min/m2 or PR fraction ≥ 20%.
Results: From May 2008 to September 2008, 89 patients
(median age 17.5 years, range 0.3 to 58.7 years) were identified
who had clinical CMR examinations using phase-contrast images
with phantom correction. The patients were referred with the
following diagnoses: 25 with tetralogy of Fallot (repaired),
17 miscellaneous, 12 other conotruncal diagnoses, 11 single
ventricle, 9 shunt lesions, 9 cardiomyopathy/myocarditis, and
6 aortic coarctation. The number and percent of patients with
clinically significant or marked changes in the phase-contrast
measurements are listed in Table 1.
Table 1 (abstract P135) Phantom correction of phase-contrast
measurements
Variable N Clinically
Significant Change
Marked
Change
MPA flow (L/min/m2) 67 29 (43%) 11 (16%)
AAO flow (L/min/m2) 85 32 (38%) 16 (19%)
RPA flow (L/min/m2) 38 9 (24%) 5 (13%)
LPA flow (L/min/m2) 33 17 (52%) 11 (33%)
Qp/Qs 64 12 (19%) 5 (8%)
PR fraction (%) 28 7 (25%) 0 (0%)
AR fraction (%) 8 3 (38%) 0 (0%)
QpR fraction (%) 30 8 (27%) 3 (10%)
Journal of Cardiovascular Magnetic Resonance 2009, 11(Suppl 1) http://jcmr-online.com/supplements/11/S1
Page 190 of 316
(page number not for citation purposes)
